As of 02 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS) for possible financing by the Department of Health (DOH) and/or the Philippine Health Insurance Corporation (PhilHealth). The HTA Council continue reading : HTA Council Preliminary Recommendation on ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS)
HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women
As of 02 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diphtheria, and pertussis for Grade 1 students (6-7 years old), Grade 7 students (11-12 years old) and pregnant women for possible government financing. continue reading : HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women